1. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, Wakeham A, Mittruecker HW, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi P, Penninger JM, and Mak TW (1996). Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551–562.
2. Ashkenazi A and Dixit VM (1998). Detah receptors: Signaling and modulation. Science 281:1305–1308.
3. Beylot-Barry M, Lamant L, Vergier B, de Muret A, Fratiag S, Delord B, Dubus P, Vaillant L, Delaunay M, Mac Grogan G, Beylot C, de Mascarel A, Delsol G, and Merlio JP (1996). Detection of t(2;5)(p23;q35) translocation by reverse transciptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 149:483–492.
4. Bowen MA, Olsen KJ, Cheng L, Avila D, and Podack ER (1993). Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. J Immunol 151:5896–5906.
5. Chalfie M, Tu Y, Euskirchen G, Ward WW, and Prasher DC (1994). Green fluorescent protein as a marker for gene expression. Science 263:802–805.